SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-21-035562
Filing Date
2021-07-02
Accepted
2021-07-02 16:16:09
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea143530-s3_aditxtherap.htm S-3 531599
2 FORM OF SENIOR INDENTURE ea143530ex4-2_aditx.htm EX-4.2 272144
3 FORM OF SUBORDINATED INDENTURE ea143530ex4-3_aditx.htm EX-4.3 274445
4 OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP AS TO THE LEGALITY OF THE SEC ea143530ex5-1_aditx.htm EX-5.1 36663
5 CONSENT OF DBBMCKENNON, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea143530ex23-1_aditx.htm EX-23.1 2304
6 GRAPHIC img_001.jpg GRAPHIC 12587
7 GRAPHIC ex5-1_001.jpg GRAPHIC 2820
  Complete submission text file 0001213900-21-035562.txt   1139733
Mailing Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043
Business Address 2569 WYANDOTTE, ST. SUITE 101 MOUNTAIN CA 94043 909-488-0844
Aditx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-257645 | Film No.: 211070274
SIC: 2834 Pharmaceutical Preparations